FSUN

Analyst Note: FSUN (FirstSun Capital Bancorp)

Date: 2026-06-13 Current Price: $36.19

1. Structural Readiness

• Conservative Entry: Not yet actionable (requires confirmed breakout).
• Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal; requires confirmation.
• Breakout Level: Not explicitly priced in the data; requires price action to establish the resistance level above the current consolidation.
• Current Price: $36.19.
• Extension: Not applicable (price is in the consolidation phase, not extended above a breakout).
• ATR Context: Current ATR is 2.8% (productive). This sits within the "productive" range, suggesting manageable volatility for position sizing, though it is below the historical "sweet spot" of 4–6% often associated with high-conviction breakouts.

2. Thesis Layer

• Thesis Classification: Tactical / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this name as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals (post-merger integration and loan growth). Do not invent a macro narrative; the conviction relies on the execution of the merger and the organic growth metrics reported in Q1 2026.

3. Business Overview

FirstSun Capital Bancorp is the financial holding company for Sunflower Bank, National Association. As of the date of this analysis, the company has recently completed a significant strategic expansion.

• Core Operations: The company operates a full-service community banking and trust business. Its subsidiaries include Sunflower Bank, Sunflower Wealth Advisors, LLC, and FEIF Capital Partners, LLC.
• Recent Strategic Action: On April 1, 2026, the company completed its merger with First Foundation. This transaction expanded the company's footprint into Southern California and Texas, and added new markets in Florida, Nevada, and Hawaii. The acquisition also brought in wealth management capabilities via First Foundation Advisors.
• Loan Portfolio & Growth:
• As of March 31, 2026, total average loans grew to $6.9 billion, an increase of $0.4 billion (6.8%) year-over-year.
• The company reported 16.2% annualized loan growth in the first quarter of 2026.
• New loan fundings totaled $528 million in Q1 2026, representing a 47% increase from Q4 2025 and a 32% increase from Q1 2025.
• Balance Sheet & Funding:
• Total assets were $8.5 billion as of December 31, 2025 (pre-merger close, but indicative of scale).
• The legacy FirstSun wholesale funding ratio was approximately 6% at the end of Q1 2026. However, the acquired First Foundation base significantly increased the wholesale funding mix post-acquisition.
• The company expects to complete the downsizing of the acquired multifamily portfolio by the end of Q2 2026.
• Net Interest Margin (NIM):
• Q1 2026 NIM was 4.25%.
• Management Expectation: Management expects full-year 2026 NIM to be in the mid-3.80s range. They anticipate a drop in the next couple of quarters due to the completion of downsizing in Q2 and the remixing of the acquired base in Q3, with NIM expected to elevate into the 3.90s range by Q4 2026.
• Repricing: Approximately $310 million in scheduled repricing is expected in the acquired multifamily portfolio for the remainder of 2026, with another $400 million in 2027.

4. Archetype and Conviction

• Archetype: Growth Leader.
• *Fit:* The company demonstrates robust organic loan growth (16.2% annualized) and successful market expansion through a completed merger. The addition of wealth management capabilities and entry into high-growth markets (CA, TX, FL, NV, HI) supports a growth narrative.
• Valuation Context:
• Forward consensus EPS is $3.595 for FY1 and $4.71 for FY2.
• At a current price of $36.19, the stock trades at approximately 10.1x FY1 EPS and 7.7x FY2 EPS.
• Conviction Stack:
• Thesis Strength: Moderate. The lack of a named secular thesis limits the "macro" tailwind, but the tactical setup is supported by strong operational data.
• Evidence Quality: High. The evidence block is robust, containing specific earnings transcript quotes and SEC filings confirming the merger, loan growth, and NIM guidance.
• Rerating Potential: Moderate. The market may re-rate the stock as the NIM stabilizes in Q4 2026 and the integration costs (wholesale funding mix) are resolved.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• A significant deterioration in the NIM guidance (e.g., management lowering the Q4 2026 target below 3.90% or the full-year target below the mid-3.80s).
• A slowdown in loan growth below the 16% annualized rate reported in Q1.
• What Would Strengthen:
• A confirmed breakout above the current consolidation range (resistance level).
• Management raising the full-year NIM guidance or confirming the Q2/Q3 remixing is proceeding faster than expected.
• Continued acceleration in new loan fundings beyond the $528 million Q1 level.
• Gaps in Evidence:
• Breakout Level: The specific resistance level required for a confirmed breakout is not explicitly stated.
• Detailed Integration Costs: While the wholesale funding mix increase is noted, specific dollar amounts for integration costs or one-time charges are not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: 16.2% annualized loan growth in Q1 2026; completed merger with First Foundation expanding footprint to CA, TX, FL, NV, HI; forward consensus EPS of $3.595 (FY1) and $4.71 (FY2). Sizing hint: Position size should be conservative given the "forming" setup status and pending NIM dip; scale in only on confirmed breakout. Expected path: Management expects NIM to dip in Q2/Q3 before recovering to 3.90s in Q4 2026; loan growth should remain robust as integration completes. Expected horizon: 3 to 6 months for the NIM stabilization and potential technical breakout.